Cell Based Assays Market to reach US$19,710.7 mn by 2022, globally: Transparency Market Research Albany – NY, Sept. 26, 2017 (GLOBE NEWSWIRE) -- The growing prevalence of chronic diseases such as cancer, arthritis, cardiovascular, diabetes, and epilepsy, increased availability of funding for...

HEPREGEN LAUNCHES FIRST MONKEY HEPATOPACTM ASSAY KITS AT ANNUAL USER GROUP MEETING CAMBRIDGE, MASS., Oct. 29, 2013 (GLOBE NEWSWIRE) -- Today, at the Company's annual User Group Meeting, Hepregen Corporation, leader in the development of next generation HepatoPacTM and...